Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China · Delayed Price · Currency is CNY 19.13
-0.32 (-1.65%)
Oct 30, 2026, 3:00 PM CST
SHA:600079 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 24,491 | 23,962 | 25,435 | 24,525 | 22,338 | 20,549 |
Revenue Growth | 1.31% | -5.79% | 3.71% | 9.79% | 8.71% | -0.63% |
Gross Profit Gross Profit Growth | 12,123 | 11,527 | 11,312 | 11,223 | 9,706 | 8,772 |
Operating Income Operating Income Growth | 3,817 | 3,571 | 3,014 | 3,319 | 2,649 | 2,361 |
Net Income Net Income Growth | 2,582 | 1,855 | 1,330 | 2,134 | 2,484 | 1,317 |
Earnings Per Share EPS Growth | 1.59 | 1.14 | 0.82 | 1.31 | 1.54 | 0.82 |
EPS Growth | 82.14% | 39.02% | -37.41% | -14.94% | 87.81% | 12.33% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 20,657 |
Overseas Overseas Growth | 3,261 |
Total Total Growth | 23,918 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,655 | 5,120 | 4,955 | 5,050 | 6,134 | 6,100 |
Total Debt Total Debt Growth | 7,904 | 8,731 | 9,274 | 9,400 | 10,253 | 12,987 |
Net Cash (Debt) Net Cash Growth | -2,249 | -3,611 | -4,319 | -4,351 | -4,119 | -6,887 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.39 | -2.22 | -2.66 | -2.67 | -2.55 | -4.29 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,652 | 2,519 | 2,164 | 1,967 | 2,441 | 2,179 |
Capital Expenditures CapEx Growth | -545.21 | -732.65 | -1,021 | -1,958 | -3,113 | -1,703 |
Free Cash Flow Free Cash Flow Growth | 2,106 | 1,786 | 1,143 | 8.93 | -672.27 | 475.78 |
Free Cash Flow Growth | 43.77% | 56.22% | 12703.33% | - | - | -52.03% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.50% | 48.11% | 44.47% | 45.76% | 43.45% | 42.69% |
Operating Margin | 15.59% | 14.90% | 11.85% | 13.53% | 11.86% | 11.49% |
Pretax Margin | 15.98% | 12.76% | 9.53% | 13.80% | 15.34% | 10.57% |
Profit Margin | 10.54% | 7.74% | 5.23% | 8.70% | 11.12% | 6.41% |
FCF Margin | 8.60% | 7.45% | 4.50% | 0.04% | -3.01% | 2.31% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.480 | 0.480 | 0.470 | 0.460 | 0.160 | 0.150 |
Dividend Per Share Growth | 50.00% | 2.13% | 2.17% | 187.50% | 6.67% | 50.00% |
Dividend Yield | 2.51% | 2.65% | 2.04% | 1.84% | 0.67% | 0.67% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.02 | 15.93 | 28.28 | 18.74 | 15.48 | 27.52 |
Forward PE | 12.86 | 12.73 | 16.14 | 18.69 | 17.73 | 28.51 |
P/FCF Ratio | 14.82 | 16.55 | 32.90 | 4478.82 | - | 76.18 |
PS Ratio | 1.27 | 1.23 | 1.48 | 1.63 | 1.72 | 1.76 |